The economic benefits of weight loss medications
Think tank: Nesta
Author(s): Various authors
June 18, 2026
This report from Nesta examines the potential economic benefits associated with weight loss medications and digital behavioural support.
To better understand the wider economic impacts of weight loss medications, Nesta partnered with Oviva to analyse real-world data from around 2,000 NHS patients living with obesity who took part in a digital weight management programme including semaglutide.
The report examines the potential economic benefits associated with weight loss medications and digital behavioural support.
